TBAJ-876
TBAJ-876 is the inhibitor of mycobacterium tuberculosis. TBAJ-876 is the analogue of the anti-tuberculosis agent Bedaquiline. TBAJ-876 has the potential for the research of tuberculosis[1].
Product Specifications
CAS Number
[2332841-25-3]
UNSPSC
12352005
Target
Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/tbaj-876.html
Purity
99.54
Solubility
10 mM in DMSO
Smiles
COC1=NC(OC)=C(OC)C([C@H](C2=CC(C=C(Br)C=C3)=C3N=C2OC)[C@@](C4=CC(OC)=NC(OC)=C4)(O)CCN(C)C)=C1
Molecular Formula
C31H37BrN4O7
Molecular Weight
657.55
References & Citations
[1]Sutherland HS, et al. Variations in the C-unit of bedaquiline provides analogues with improved biology and pharmacology. Bioorg Med Chem. 2020;28 (1) :115213.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
040544-ML405 100 µL
PSG6, NT (PSG6, CGM3, PSG10, PSG12, PSGGB, Pregnancy-specific beta-1-glycoprotein 6, Pregnancy-specific beta-1-glycoprotein 10, Pregnancy-specific beta-1-glycoprotein 12) (MaxLight 405) discontinued
Ask
View Details 